Hemostasis Reference Laboratory

DNA Factor VIII Inversion

  • Transaction code: 3250-05
  • CPT codes (suggested): 83890, 83900 (x2), 83901 (x11), 83892, 83894 (x3), 83912

In severe hemophilia A, a common recurrent intron 22 gene inversion accounts for ~45% of the cases. A recurrent intron 1 inversion accounts for ~5% of the cases. These two sites are the first to be screened for severe hemophilia A patients.

Method
Evaluation of Introns 1 and 22 are performed using PCR-SSP analysis by standard PCR and long range PCR, respectively. Confirmation for the intron 22 inversion will be performed using inverse PCR. For intron 1 inversions, confirmation will be performed by repeating the test with the same method.

If the mutation is not identified, further screening can be performed by DNA Hemophilia A Mutation Evaluation testing information.

Testing Details

  • Turnaround time: FVIII inversion testing takes 1-2 weeks.
  • Sample Requirements: 5-10mL whole blood drawn in EDTA and shipped at 4°C or ambient temperature is acceptable. Refer to the sample requirements page for more information on shipping.
  • Analysis of amniocytes can be performed on cultured amniocytes. Two T-25 flasks of cells cultured to confluency will be accepted. Puget Sound Blood Center does not have facilities to culture amniocytes.
  Questions: 206-292-6594